Abbott India profit and loss

Latest FY26
Revenue
₹6,929cr+8.1% on FY25
EBITDA
₹1,892cr+11.7% on FY25
₹ crore except per share
Tap a line for its trendFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
6,9296,4095,8495,349
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
288276248154
7,2176,6856,0975,503
Expenses
614621566559
3,1643,0562,6472,350
−85.3——66.1
669588577564
25.011.412.516.0
76.071.871.270.0
675—599604
5,1384,7984,4794,229
1,8921,6951,4531,206
1,8161,6231,3821,136
Profit
2,0791,8871,6181,274
54524.739.249.3
−10.7———
527473417324
1,5521,4141,201949
−0.9−5.40.03.6
1,5511,4091,201953
Per share
——₹565.28₹446.78
Derived — gross profit (revenue − materials − purchases − Δ inventories)
3,2362,7322,6362,374
46.7%42.6%45.1%44.4%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

ABBOTINDIA₹26,275.00

Abbott India Ltd.

· Pharma & Health
AnnualQuarterly₹ CrorePeersPFIZERGLAXOIPCALABAJANTPHARMANTHEMMEDANTAGLENMARKBIOCON
View
In ₹ Crore except Per Share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Revenue from Operations5,348.75,848.96,409.26,929.1
Other Income154.2248.3275.6288.1
Total Income5,502.96,097.26,684.77,217.2
Expenses
+ Cost of Materials Consumed558.6565.7621.1613.9
+ Purchases of Stock-in-Trade2,350.42,647.23,056.33,164.2
+ Changes in Inventories66.1——-85.3
+ Employee Benefit Expense563.6576.6587.5668.8
+ Finance Costs16.012.511.425.0
+ Depreciation & Amortisation70.071.271.876.0
+ Other Expenses604.5598.6—675.3
Total Expenses4,229.14,479.44,797.85,137.9
EBITDA1,205.61,453.11,694.61,892.1
EBIT1,135.71,381.91,622.81,816.1
Profit
Pretax Income1,273.81,617.81,887.02,079.3
+ Current Tax49.339.224.7544.7
+ Deferred Tax———-10.7
Tax Expense324.4416.5472.5527.3
Net Income949.41,201.21,414.41,552.0
+ Other Comprehensive Income3.60.0-5.4-0.9
Total Comprehensive Income953.01,201.21,409.01,551.2
Per Share
Basic EPS446.78565.28——
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit2,373.72,636.02,731.73,236.2
Gross Margin %44.3845.0742.6246.71
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 85%.